Patent ID: 8609106
Filing Date: 2013-12-17
Classification: A61K,A61P

Abstract:
1. An immunogenic composition comprising at least two of: (a) a first polypeptide comprising a first amino acid sequence, where the first amino acid sequence comprises an amino acid sequence (i) having at least 90% sequence identity to SEQ ID NO: 1 and/or (ii) consisting of a fragment of at least 7 contiguous amino acids from SEQ ID NO: 1; (b) a second polypeptide, comprising a second amino acid sequence, where the second amino acid sequence comprises an amino acid sequence (i) having at least 90% sequence identity to SEQ ID NO: 2 and/or (ii) consisting of a fragment of at least 50 contiguous amino acids from SEQ ID NO: 2; and/or (c) a third polypeptide, comprising a third amino acid sequence, where the third amino acid sequence comprises an amino acid sequence (i) having at least 90% sequence identity to SEQ ID NO: 3 and/or (ii) consisting of a fragment of at least 29 contiguous amino acids from SEQ ID NO: 3.